These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3350998)

  • 1. S-adenosyl-L-methionine in the treatment of Alzheimer's disease.
    Cohen BM; Satlin A; Zubenko GS
    J Clin Psychopharmacol; 1988 Feb; 8(1):43-7. PubMed ID: 3350998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane abnormality in Alzheimer's disease.
    Zubenko GS; Cohen BM; Boller F; Malinakova I; Keefe N; Chojnacki B
    Ann Neurol; 1987 Aug; 22(2):237-44. PubMed ID: 3662454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity.
    Hashimoto M; Hossain S; Shimada T; Shido O
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):934-9. PubMed ID: 17002670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane fluidity in Alzheimer's disease and major depression.
    Zubenko GS; Cohen BM; Reynolds CF; Boller F; Malinakova I; Keefe N
    Am J Psychiatry; 1987 Jul; 144(7):860-8. PubMed ID: 3605398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood viscosity and red cell morphology in subjects suffering from cirrhosis before and after treatment with S-adenosyl-L-methionine (SAM).
    Turchetti V; Bellini MA; Leoncini F; Petri F; Trabalzini L; Guerrini M; Forconi S
    Clin Hemorheol Microcirc; 2000; 22(3):215-21. PubMed ID: 10976715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
    Reisberg B; Borenstein J; Salob SP; Ferris SH; Franssen E; Georgotas A
    J Clin Psychiatry; 1987 May; 48 Suppl():9-15. PubMed ID: 3553166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane fluidity of blood cells.
    Hollán S
    Haematologia (Budap); 1996; 27(3):109-27. PubMed ID: 14653448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
    Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
    Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
    Shinagawa Y; Nakaaki S; Hongo J; Murata Y; Sato J; Matsui T; Tatsumi H; Akechi T; Furukawa TA
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):951-6. PubMed ID: 17299806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
    Piletz JE; Sarasua M; Whitehouse P; Chotani M
    Neurobiol Aging; 1991; 12(5):401-6. PubMed ID: 1770973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population.
    Sinforiani E; Banchieri LM; Zucchella C; Bernasconi L; Nappi G
    Funct Neurol; 2003; 18(4):233-7. PubMed ID: 15055749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.
    Shi C; Guo K; Yew DT; Yao Z; Forster EL; Wang H; Xu J
    Exp Gerontol; 2008 Jun; 43(6):589-94. PubMed ID: 18359596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of gender on platelet membrane functions of Alzheimer's disease patients.
    Vignini A; Giusti L; Raffaelli F; Giulietti A; Salvolini E; Luzzi S; Provinciali L; Mazzanti L; Nanetti L
    Exp Gerontol; 2013 Mar; 48(3):319-25. PubMed ID: 23228953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.